Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function
Herold K, Gitelman S, Gottlieb P, Knetch L, Raymond R, and Ramos E
Diabetes Care. 2023 Oct 1;46(10):1848-1856
https://doi.org/10.2337/dc23-0675

Implementation of fully closed-loop insulin delivery for inpatients with diabetes: Real-world outcomes
Boughton C, Hartnell S, Hobday N, Lake A, Davenport K Et al
Diabet Med. 2023 Jun;40(6):e15092.
https://doi.org/10.1111/dme.15092